| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Laurence Marton is Director at MTTN and has filed Form 4s across 2 companies. Laurence Marton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $205K at current prices.
Historically, Laurence Marton's trades have earned a middling insider score of 64/100 across 3 rated trades. Over a 12-month horizon, both of those trades were profitable, with an average 12-month return of +24.4%.
The biggest single holding is MTTN (~$192K) as Director.
Laurence Marton has 13 Form 4 filings on record from October 2021 to October 2026, across 2 companies: Director at RenovoRx (RNXT), 2021–2026; Director at Matternet (MTTN), 2026.
The 18 reported transactions were 10 option or other derivative awards, 5 open-market purchases, 2 option exercises and 1 stock award.
Counted by filing, the open-market trades come to 1 purchase worth about $10K and no sales.
The only open-market purchase was 12,050 shares of RNXT at an average $0.85 on April 8, 2025, about $10K. Twelve months later RNXT was up 17%.